4-(Chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide, 95+%, 5g

4-((2-(Dimethylamino)ethoxy)(phenyl)methyl)aniline, 95.0%, 100mg

2-((Tetrahydro-2H-pyran-2-yl)methoxy)benzoic acid, 97.0%, 100mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-fluoro-1H-indol-3-yl)propanoic acid, 98%, 250mg

2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 5g

1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone, 95.0%, 10g

1-(Chloromethyl)-3-fluoro-5-nitrobenzene, 95.0%, 5g

3-(CYCLOPENTYLOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-METHOXYBENZAMIDE, 95%, 10mg

Patent blue VF (CI 42045), purest, 10 g, glass packaging

4-Chlorophenylacetic acid, 98.0%, 500g

N-(4-methoxybenzyl)pyridazin-3-amine, 98%, 10g

(R)-Methyl 2-amino-2-cyclohexylacetate hydrochloride, 95.0%, 100g

1-(3,4-Dimethylphenyl)cyclopropan-1-amine, 95%, 5g